barcode ligation (Danaher Inc)
Danaher Inc is a verified supplier 
Danaher Inc manufactures this product 
96
Structured Review
Danaher Inc
barcode ligation
Barcode Ligation, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 96/100, based on 690 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/barcode+adapter+ligation/Adapters/med_rxiv__2025__04__25__25325254-141-1-29
Average 96 stars, based on 690 article reviews
Barcode Ligation, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 96/100, based on 690 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/barcode+adapter+ligation/Adapters/med_rxiv__2025__04__25__25325254-141-1-29
Average 96 stars, based on 690 article reviews
barcode ligation - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Adapter Ligation:Article Title: Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition. Article Snippet: Next-generation sequencing (NGS) analysis was performed using SOPHIA Genetics Myeloid Solution panel (Sophia Genetics, Saint Sulpice, Switzerland), covering 30 genes (ABL1, ASXL1, BRAF, CALR, CBL, CEBPA, CSF3R, DNMT3A, ETV6, EZH2, FLT3, HRAS, IDH1, IDH2, JAK2, KIT KRAS, MPL, NPM1, NRAS, PTPN11, RUNX1, SETBP1, SF3B1, SRSF2, TET2, TP53, U2AF1, WT1, ZRSR2). .. Briefly, samples were first diluted with IDTE (10 mM Tris, 0.1 mM EDTA) buffer to obtain 200 ng of DNA in 30 μL of final volume, and then library preparation was initiated with enzymatic DNA fragmentation, followed by Article Title: Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach Article Snippet: An amplicon library was produced from 10ng of DNA from each sample using the Ion AmpliSeqTMCancer Hotspot Panel v2 that generates 207 amplicons encompassing hotspot and targeted regions of 50 genes (ABL1, EGFR, GNAS, KRAS, PTPN11, AKT1, ERBB2, GNAQ, MET, RB1, ALK, ERBB4, HNF1A, MLH1, RET, APC, EZH2, HRAS, MPL, SMAD4, ATM, FBXW7, IDH1, NOTCH1, SMARCB1, BRAF, FGFR1, JAK2, NPM1, SMO, CDH1, FGFR2, JAK3, NRAS, SRC, CDKN2A, FGFR3,IDH2,PDGFRA,STK11,CSF1R,FLT3,KDR,PIK3CA,TP53,CTNNB1,GNA11,KIT,PTEN,VHL) . .. Amplification of target sequences was followed by Purification:Article Title: Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition. Article Snippet: Next-generation sequencing (NGS) analysis was performed using SOPHIA Genetics Myeloid Solution panel (Sophia Genetics, Saint Sulpice, Switzerland), covering 30 genes (ABL1, ASXL1, BRAF, CALR, CBL, CEBPA, CSF3R, DNMT3A, ETV6, EZH2, FLT3, HRAS, IDH1, IDH2, JAK2, KIT KRAS, MPL, NPM1, NRAS, PTPN11, RUNX1, SETBP1, SF3B1, SRSF2, TET2, TP53, U2AF1, WT1, ZRSR2). .. Briefly, samples were first diluted with IDTE (10 mM Tris, 0.1 mM EDTA) buffer to obtain 200 ng of DNA in 30 μL of final volume, and then library preparation was initiated with enzymatic DNA fragmentation, followed by Article Title: Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach Article Snippet: An amplicon library was produced from 10ng of DNA from each sample using the Ion AmpliSeqTMCancer Hotspot Panel v2 that generates 207 amplicons encompassing hotspot and targeted regions of 50 genes (ABL1, EGFR, GNAS, KRAS, PTPN11, AKT1, ERBB2, GNAQ, MET, RB1, ALK, ERBB4, HNF1A, MLH1, RET, APC, EZH2, HRAS, MPL, SMAD4, ATM, FBXW7, IDH1, NOTCH1, SMARCB1, BRAF, FGFR1, JAK2, NPM1, SMO, CDH1, FGFR2, JAK3, NRAS, SRC, CDKN2A, FGFR3,IDH2,PDGFRA,STK11,CSF1R,FLT3,KDR,PIK3CA,TP53,CTNNB1,GNA11,KIT,PTEN,VHL) . .. Amplification of target sequences was followed by Amplification:Article Title: Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach Article Snippet: An amplicon library was produced from 10ng of DNA from each sample using the Ion AmpliSeqTMCancer Hotspot Panel v2 that generates 207 amplicons encompassing hotspot and targeted regions of 50 genes (ABL1, EGFR, GNAS, KRAS, PTPN11, AKT1, ERBB2, GNAQ, MET, RB1, ALK, ERBB4, HNF1A, MLH1, RET, APC, EZH2, HRAS, MPL, SMAD4, ATM, FBXW7, IDH1, NOTCH1, SMARCB1, BRAF, FGFR1, JAK2, NPM1, SMO, CDH1, FGFR2, JAK3, NRAS, SRC, CDKN2A, FGFR3,IDH2,PDGFRA,STK11,CSF1R,FLT3,KDR,PIK3CA,TP53,CTNNB1,GNA11,KIT,PTEN,VHL) . .. Amplification of target sequences was followed by |